Formation of nitric oxide-derived oxidants by myeloperoxidase in monocytes pathways for monocyte-mediated protein nitration and lipid peroxidation in vivo

Circulation Research

Volumn 85, Issue 10, 1999, Pages 950-958

  Hazen, Stanley L ^a,b   Zhang, Renliang ^a   Shen, Zhongzhou ^a   Wu, Weijia ^b   Podrez, Eugene A ^a   MacPherson, Jennifer C ^a   Schmitt, David ^a   Mitra, Shome N ^a   Mukhopadhyay, Chaitali ^a   Chen, Yonghong ^b   Cohen, Peter A ^a   Hoff, Henry F ^a,b   Abu Soud, Husam M ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b CLEVELAND STATE UNIVERSITY   (United States)

Author keywords

Atherosclerosis; Lipid peroxidation; Nitric oxide; Nitrotyrosine

Indexed keywords

MYELOPEROXIDASE; NITRIC OXIDE;

ARTICLE; CONTROLLED STUDY; GAS CHROMATOGRAPHY; HUMAN; HUMAN CELL; LEUKOCYTE ACTIVATION; LIPID METABOLISM; MASS SPECTROMETRY; MONOCYTE; NITRATION; PEROXIDATION; PRIORITY JOURNAL;

EID: 0032739169     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.85.10.950     Document Type: Article

References (57)

1. Witzlum JL, Steinberg D. Role of oxidized low density lipoprotein in atherogenesis. J Clin Invest. 1991;88:1785-1792.
2. Steinbrecher UP, Zhang HF, Lougheed M. Role of oxidatively modified LDL in atherosclerosis. Free Radic Biol Med. 1990;9:155-168.
3. Chisolm GM, Penn MS. Oxidized lipoproteins and atherosclerosis. In: Fuster V, Ross R, Topol EJ, eds. Atherosclerosis and Coronary Artery Disease. Philadelphia: Lippincott-Raven; 1998:129-149.
4. Berliner JA, Navab M, Fogelman AM, Frank JS, Demer LL, Edwards PA, Watson AD, Lusis AJ. Atherosclerosis: basic mechanisms, oxidation, inflammation and genetics. Circulation. 1995;91:2488-2496.
5. Beckman JS, Ye YZ, Anderson PG, Chen J, Accavitti MA, Tarpey MM, White R. Extensive nitration of protein tyrosines in human atherosclerosis detected by immunohistochemistry. Biol Chem Hoppe Seyler. 1993;375:81-88.
6. Leeuwenburgh C, Hardy MM, Hazen SL, Wagner P, Ohishi S, Steinbrecher UP, Heinecke JW. Reactive nitrogen intermediates promote low density lipoprotein oxidation in human atherosclerotic intima. J Biol Chem. 1997;272:1433-1436.
7. Podrez EA, Schmitt D, Hoff HF, Hazen SL. Myeloperoxidase-generated reactive nitrogen species convert LDL into an atherogenic form in vitro. J Clin Invest. 1999;103:1547-1563.
8. Moncada S, Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med. 1993;329:2002-2012.
9. Beckman JS, Chen J, Ischiropoulos H, Crow JP. Oxidative chemistry of peroxynitrite. Methods Enymol. 1994;233:229-240.
10. van der Vliet A, Eiserich JP, Kaur H, Cross CE, Halliwell B. Nitrotyrosine as biomarker for reactive nitrogen species. Methods Enzymol. 1996;269: 175-184.
11. Patel RP, McAndrew J, Sellak H, White CR, Jo H, Freeman BA, Darley-Usmar VM. Biological aspects of reactive nitrogen species. Biochem Biophys Acta. 1999;1411:385-400.
12. Forstermann U, Kleinert H, Gath I, Schwartz P, Closs EI, Dun NJ. Expression and expressional control of nitric oxide synthases in various cell types. In: Ignarro L, Murad F, eds. Nitric Oxide: Biochemistry, Molecular Biology, and Therapeutic Implications. San Diego, Calif: Academic Press; 1995:171-186.
13. Babior BM. Oxygen-dependent microbial killing by phagocytes. N Engl J Med. 1978;298:659-663.
14. Klebanoff SJ. Oxygen metabolism and the toxic properties of phagocytes. Ann Intent Med. 1980;93:480-489.
15. Smith JD, Trogan E, Ginsberg M, Grigaux C, Tian J, Miyata M. Decreased atherosclerosis in mice deficient in both macrophage colony-stimulating factor (op) and apolipoprotein E. Proc Natl Acad Sci U S A. 1995;92: 8264-8268.
16. Jessup W, Mohr D, Gieseg SP, Dean RT, Stocker R. The participation of nitric oxide in cell free- and its restriction of macrophage-mediated oxidation of low-density lipoprotein. Biochem Biophys Acta. 1992;1180:73-82.
17. Halliwell B. What nitrates tyrosine? Is nitrotyrosine specific as a biomarker of peroxynitrite formation in vivo? FEBS Lett. 1997;411:157-160.
18. Hogg N, Struck A, Goss SP, Santanam N, Joseph J, Parthasarathy S, Kalyanaraman B. Inhibition of macrophage-dependent low density lipoprotein oxidation by nitric-oxide donors. J Lipid Res. 1995;36: 1756-1762.
19. Goss SP, Hogg N, Kalyanaraman B. The effect of nitric oxide release rates on the oxidation of human low density lipoprotein. J Biol Chem. 1997;272: 21647-21653.
20. Darley-Usmar VM, Hogg N, O'Leary VJ, Wilson MT, Moncada S. The simultaneous generation of superoxide and nitric oxide can initiate lipid peroxidation in human low density lipoprotein. Free Radic Res Commun. 1992;17:9-20.
21. Radi R, Beckman JS, Bush KM, Freeman BA. Peroxynitrite-induced membrane lipid peroxidation: the cytotoxic potential of superoxide and nitric oxide. Arch Biochem Biophys. 1991;288:481-487.
22. Hogg N, Darley-Usmar VM, Wilson MT, Moncada S. The oxidation of α-tocopherol in human low-density lipoprotein by the simultaneous generation of superoxide and nitric oxide. FEBS Lett. 1993;326:199-203.
23. Goss SP, Hogg N, Kalyanaraman B. The effect of a-tocopherol on the nitration of γ-tocopherol by peroxynitrite. Arch Biochem Biophys. 1999;363: 333-340.
24. Graham A, Hogg N, Kalyanaraman B, O'Leary V, Darley-Usman V, Moncada S. Peroxynitrite modification of low-density lipoprotein leads to recognition by the macrophage scavenger receptor. FEBS Lett. 1993;330: 181-185.
25. Lymar SV, Jiang Q, Hurst JK. Mechanism of carbon dioxide-catalyzed oxidation of tyrosine by peroxynitrite. Biochemistry. 1996;35:7855-7861.
26. Radi R, Denicola A, Freeman BA. Peroxynitrite reactions with carbon dioxide-bicarbonate. Methods Enzymol. 1999;301:353-367.
27. Eiserich JP, Cross CE, Jones AD, Halliwell B, van der Vieil A. Formation of nitrating and chlorinating species by reaction of nitrite with hypochlorous acid: a novel mechanism for nitric oxide-mediated protein modification. J Biol Chem. 1996;271:19199-19208.
28. van der Vleit A, Eiserich JP, Halliwell B, Cross CE. Formation of reactive nitrogen species during peroxidase-catalyzed oxidation of nitrite: a potential additional mechanism of nitric oxide-dependent toxicity. J Biol Chem. 1997; 272:7617-7625.
29. Eiserich JP, Hristova M, Cross CE, Jones AD, Freeman BA, Halliwell B. Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils. Nature. 1998;391:393-397.
30. Jiang Q, Hurst JK. Relative chlorinating, nitrating and oxidizing capabilities of neutrophil determined with phagocytosable probes. J Biol Chem. 1997; 272:32767-32772.
31. Daugherty A, Dunn JL, Rateri DL, Heinecke JW. Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions. J Clin Invest. 1994;94:437-444.
32. Hazen SL, Crowley JR, Mueller DM, Heinecke JW. Mass spectrometric quantification of 3-chlorotyrosine in human tissues with attomole sensitivity: a sensitive and specific marker for myeloperoxidase-catalyzed chlorination at sites of inflammation. Free Radic Biol Med. 1997;23:909-916.
33. Fukuto JM. Chemistry of nitric oxide: biologically relevant aspects. In: Ignarro L, Murad F, eds. Nitric Oxide: Biochemistry, Molecular Biology, and Therapeutic Implications. San Diego, Calif: Academic Press; 1995:1-16.
34. Schmitt D, Shen Z, Zhang R, Colles SM, Wu W, Salomon RG, Chen Y, Chisolm GM, Hazen SL. Leukocytes utilize myeloperoxidase-generated nitrating intermediates as physiological catalysts for the generation of biologically active oxidized lipids and sterols in serum. Biochemistry. In press.
35. Panasenko OM, Briviba K, Klotz LO, Sies H. Oxidative modification and nitration of human low-density lipoproteins by the reaction of hypochlorous acid with nitrite. Arch Biochem Biophys. 1997;343:254-259.
36. Markwell MA, Haas SM, Bieber LL, Tolbert NE. A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal Biochem. 1978;87:206-210.
37. 3 solutions in the UV). Anal Biochem. 1972;49:474-478.
38. Schmidt HHHW, Keim M. Determination of nitrite and nitrate by the Griess reaction. In: Feelisch M, Stamler JS, eds. Methods in Nitric Oxide Research. New York: John Wiley & Sons Ltd; 1996:491-497.
39. Czerniecki BJ, Carter C, Rivoltini L, Koski GK, Kim HI, Weng DE, Roros JG, Hijazi YM. Xu S, Rosenberg SA, Cohen PA. Calcium ionophore-treated peripheral blood monocytes and dendritic cells rapidly display characteristics of activated dendritic cells. J Immunol. 1997;159:3823-3837.
40. Mooradian DL, Hutsell TC, Keefer LK. Nitric oxide (NO) donor molecules: effect of NO release rate on vascular smooth muscle cell proliferation in vitro. J Cardiovasc Pharmacol. 1995;25:674-678.
41. Baek KJ, Thiel BA, Lucas S, Stuehr DJ. Macrophage nitric oxide synthase subunits: purification, characterization, and role of prosthetic groups and substrate in regulating their association into a dimeric enzyme. J Biol Chem. 1993;268:21120-21129.
42. 2α by human monocytes: discriminate production by reactive oxygen species and prostaglandin endoperoxide synthase-2. J Biol Chem. 1996;271:8919-8924.
43. Hazen SL, Hsu FF, Gaut JP, Crowley JR, Heinecke JW. Modification of proteins and lipids by myeloperoxidase-derived oxidants. Methods Enzymol. 1999;300:88-105.
44. Crowley JR, Yarasheski K, Leeuwenburgh C, Turk J, Heinecke JW. Isotope dilution mass spectrometric quantification of 3-nitrotyrosine in proteins and tissues is facilitated by reduction to 3-aminotyrosine. Anal Biochem. 1998; 259:127-135.
45. Hazen SL, Hsu FF, Mueller DM, Crowley JR, Heinecke JW. Human neutrophils employ chlorine gas as an oxidant during phagocytosis. J Clin Invest. 1996;98:1283-1289.
46. Savenkova ML, Mueller DM, Heinecke JW. Tyrosyl radical generated by myeloperoxidase is a physiological catalyst for the initiation of lipid peroxidation in low density lipoprotein. J Biol Chem. 1994;269:20394-20400.
47. Liu TZ, Stern A, Morrow JD. The isoprostanes: unique bioactive products of lipid peroxidation. An overview. J Biomed Sci. 1998;5:415-420.
48. Mallat Z, Nakamura T, Ohan J, Leseche G, Tedgui A, Maclouf J, Murphy RC. The relationship of hydroxyeicosatetraenoic acids and F2-isoprostanes to plaque instability in human carotid atherosclerosis. J Clin Invest. 1999;103: 421-427.
49. Kettle AJ, Winterbourn CC. Myeloperoxidase: a key regulator of neutrophil oxidant production. Redox Rep. 1997;3:3-15.
50. Fridovich I. CAC Handbook of Methods: Oxygen Radical Research. Boca Raton. Fla: CRC Press: 1985:213-215.
51. Nelson SK, Bose SK, McCord JM. The toxicity of high-dose superoxide dismutase suggests that superoxide can both initiate and terminate lipid peroxidation in the reperfused heart. Free Radic Biol Med. 1994;16:195-200.
52. Test ST, Lampert MB, Ossanna PJ, Thoene JG, Weiss SJ. Generation of nitrogen-chlorine oxidants by human phagocytes. J Clin Invest. 1984;74: 1341-1349.
53. Lampert MB, Weiss SJ. The chlorinating potential of the human monocyte. Blood. 1983;62:645-651.
54. Sampson JB, Ye Y, Rosen H, Beckman JS. Myeloperoxidase and horseradish peroxidase catalyze tyrosine nitration in proteins from nitrite and hydrogen peroxide. Arch Biochem Biophys. 1998;356:207-213.
55. Hogg N, Kalyanaraman B. Nitric oxide and lipid peroxidation. Biochem Biophys Acta. 1999;1411:378-384.
56. Harrison RJ. Textbook of Medicine with Relevant Physiology and Anatomy. Vol XXII. London: Hoddur & Stroughton; 1977.
57. Lymar SV, Hurst JK. Carbon dioxide: physiological catalyst for peroxynitrite-mediated cellular damage or cellular protectant? Chem Res Toxicol. 1996;9:845-850.